OmicScouts

OmicScouts integrates quantitative mass spectrometry-based proteomics and bioinformatics with biochemical and cell culture services to advance clients drug discovery, disease biology, and clinical research. OmicScouts technologies enable unbiased and comprehensive identification of drug targets, drug selectivity, target engagement, mode of action analyses, and the discovery of pharmacodynamics and drug response biomarkers

Proteomics,drug discovery,biomarker discovery,mass spectrometry,protac selectivity,moa investigation,phosphoproteomics,compound-induced signaling,human ipsc neuronal culture,cell culture,bioinformatics,target deconvolution,and chemical proteomics

Omicscouts operates in the Biotechnology research industry.

Omicscouts's revenue is 11m - 100m

Omicscouts has 11 - 50 employees.